WADA M,NAGASAWA H,ISEKI C,et al.Cerebral small vessel disease and chronic kidney disease(CKD):results of a cross-sectional study in community-based Japanese elderly [ J ].J Neu-rol Sci,2008,272(1/2):36-42.Wada M, Nagasawa H, Iseki C, Takahashi Y, Sato H, Arawaka S, et al. ...
Chronic small vessel disease (SVD) has been shown to disrupt this network’s integrity and has been proposed as a predictor of poor outcome after stroke. We studied this hypothesis in patients with acute ischemic stroke of the striatocapsular region, an area of pronounced cortical and ...
Cerebral small vessel disease can be identified using magnetic resonance imaging, and includes white matter hyperintensities, lacunar infarcts, cerebral microbleeds, and brain atrophy. Cerebral small vessel disease and chronic kidney disease share many risk factors, including hypertension. This study aims ...
Using large-scale, cross-sectional and longitudinal cohorts (N = 9,344), we have developed an MRI-based brain age model (N = 6,725) to evaluate the difference between brain age and chronological age, termed ‘predicted age difference’ (PAD), across several common types of CMP ...
The global incidence of Chronic Kidney Disease (CKD) is steadily escalating, with discernible linkage to the intricate terrain of intestinal microecology. The intestinal microbiota orchestrates a dynamic equilibrium in the organism, metabolizing dietary-
We aimed to evaluate whether white and gray matter microstructure changes observed with magnetic resonance imaging (MRI)-based diffusion tensor imaging (DTI) can be used to reflect the progression of chronic brain trauma. The MRI-DTI parameters, neuropat
Fujitani RM, Mills JL. Acute and chronic upper extremity ischemia. I. Large vessel arterial occlusive disease. Ann Vasc Surg, 1993, 7:106-112. (收稿日期:2013-07-01) (助理编辑:曹洪红 )Joseph L. Mills,Roy M. Fujitani.Acute and chronic upper extremity ischemia. II. Small vessel arterial ...
This is an important finding since a small percent of papillary NMIUC’s progress to the muscle invasive form and the molecular mechanisms associated with the progression are unknown. Our study demonstrates that at least in an animal model, the progression involves the upregulation of some of ...
Immunohistochemical neuronal biomarkers can be used to measure the protein levels of specific proteins released into the circulation by brain cell injury, blood vessel injury, and inflammation. For example, the neuronal nuclei antigen (NeuN) can be used as a quantitative measure to identify the neuro...
Animal models provide some evidence that AKI sustained in this way can have long-term kidney consequences; after ischemia-reperfusion injury, cellular damage of the endothelial and tubular cells within the kidney leads to endothelial cell differentiation, impaired regenerative capacity, vascular dropout ...